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Abstract 
Background: Limitation of care (LC) is common practice in intensive care units (ICUs) and is 
associated with high mortality. There is no consensus on its application or the process in itself, 
sometimes leading futile prolongation of life and greater suffering.  
Objectives: We aimed to study types of LC, associated mortality and factors that influence end-
of-life decisions. 
Material and method: This was a 2-year (2004-2006) prospective observational study of 97 
patients in whom LC who was applied. Age, diagnosis on admission, severity scales, life support 
techniques, sedation and analgesia, modality of LC (withdrawal or withholding) and the justification for 
LC were recorded. 
Results: We applied LC to 6.6 % of the patients admitted to ICU with a mortality rate of 89.6 % 
(30.3 % of all deaths).The average stay of these patients was 10.5 ± 5.5 days compared to 5.6 ± 4.3 
days for patients in whom LC was not implemented (p<0.001). The mean±SD length of stay from start 
of LC until death was 68±50 hours. The most frequent diagnosis on admission was sepsis (30.9%) 
and the futility was the reason given most often for LC (85%). Withdrawal of life support was used 
more frequently (65%) than withholding and was associated with higher mortality (95.3%). 
Conclusions: The severity criteria on admission to the ICU did not influence the decision to 
implement LC. Likewise, the modality of LC did not influence patient survival. 
Keys Words: limitation of care; withdrawal of life support; withholding life support; futility. 
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Resumen 
Introducción: La limitación del esfuerzo terapéutico (LET) es una práctica frecuente en los 
Servicios de Medicina Intensiva (SMI) que asocia a una mortalidad elevada. Sin embargo no hay 
consenso establecido en cuanto a su aplicación ni al proceso en sí derivando en ocasiones a una 
prolongación fútil de la vida y a un mayor sufrimiento. Analizamos las características epidemiológicas, 
la modalidad retirada del soporte vital (RSV) frente al no inicio (NISV) del mismo, la mortalidad y la 
frecuencia de variables que determinan el inicio del proceso de decisión al final de la vida.  
Objetivos. Analizar la modalidad más utilizada en la limitación del esfuerzo terapéutico, 
identificar los factores que la determinan y su implicación en la supervivencia. 
Material y método: Estudio observacional, descriptivo y prospectivo durante 2 años (2004-
2006) sobre 97 pacientes a los que se aplicó LET. Los datos recogidos fueron: la edad, diagnóstico al 
ingreso, escalas de gravedad, soporte aplicado, sedación y analgesia, modalidad de la LET y la 
causa que motivó la toma de decisión.  
Resultados: Se aplicó LET al 6,6% de los pacientes ingresados en SMI con una mortalidad del 
89,6% (30,3% del total de fallecimientos). La estancia media de estos pacientes fue de 10.5 ± 5,5 
días frente a 5.6 ± 4,3 dias en los paciente donde no se les practicó ninguna modalidad de LET 
(p<0,001) con una estancia media desde el inicio de la LET hasta el fallecimiento de 68 ± 50 horas. El 
diagnóstico al ingreso más frecuente fue la sepsis (30,9%) y la futilidad fue el motivo de LET más 
repetido (85%). La RSV se empleó con más frecuencia (65%) que la modalidad NISV y se asoció a 
mayor mortalidad (95,3%).  
Conclusiones: Los criterios de gravedad al ingreso en el SMI no determinan la decisión de 
aplicar la limitación del esfuerzo terapéutico. Tampoco influyen en la supervivencia de los pacientes la 
modalidad de LET utilizada.  
Palabras clave: limitación del esfuerzo terapéutico; retirada del soporte vital; no inicio del 
soporte vital; futilidad. 
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Introduction 
Limitation of care (LC) is common practice in intensive care units (ICUs) and is associated with 
high mortality. However, there is no established consensus on when or how it should be applied and, 
at times, futile attempts to prolong life may lead to greater suffering for the patients. From the ethical 
point of view, the decision to withhold life support is no different to the decision to withdraw it, as 
recognized by a number of authors [1,2,3,4]. 
Often, personal views of the intensivist influence decisions about LC although this is 
inappropriate from the ethical standpoint and hinders the application of a uniform standard of care. In 
studies published on the opinion of health-care professionals, prior quality of life (92%) and future 
predicted quality of life (83%) are taken into account [5]. It is also true that physicians underestimate 
the quality of life of patients, whereas patients are more optimistic and are more tolerant of their 
limitations [6]. In practice, although the recommendations are fully clear, withdrawal of life support is 
only acceptable for reasons of physiological futility such as, for example, brain death, patients with 
end-stage multiorgan failure and patients in a vegetative state.  
In our study, we aimed to compare withdrawal of life support with withholding of life support and 
analyze the variables that determine the initiation of the decision process at the end of life.  
Material and methods 
In this prospective, observational, descriptive study conducted between 1 February 2004 and 28 
February 2008, we included 97 patients in whom either withdrawal or withholding of life support was 
practiced. The study was conducted in the Intensive Care Unit of our hospital, with a catchment 
population of approximately 250,000 people. It has 350 beds, with all medical and surgical specialties 
represented except neurosurgery and cardiovascular surgery. The ICU has 14 beds and admits, on 
average, 700 patients/year, with a mean stay of 5.6 days. During the study period, 1458 patients were 
admitted to the unit. In 97 patients (6.6%), some form of LC was practiced. These patients were 
studied prospectively until they died or were discharged from the unit.  
The following data were collected for each subject: age, sex, diagnosis on admission, 
Sequential Organ Failure Assessment (SOFA) at the time of inclusion, Acute Physiology and Chronic 
Health Evaluation (APACHE) II on admission, life support measures during admission (mechanical 
ventilation, vasoactive drugs, dialysis, antimicrobial therapy, artificial nutrition), type of LC (withdrawal 
or withholding of life support), number of failing organs when the decision was made, comorbidity, and 
the rationale for the decision (futility, prior quality of life or suffering). Withholding or withdrawal of life 
support was defined as the decision not to apply a medical intervention either by not resorting to it 
(withholding) or renouncing it when the intervention was not meeting its therapeutic goals (withdrawal). 
Quality of life was defined as the subjective perception of an individual of living in a dignified state. In 
our study, in accordance with Rivera Fernández et al [7], we defined four levels of quality of life, based 
on basic physiologic areas: physical activity, dependence on therapeutic measures, and occupational 
activity. We defined suffering according to the definition proposed by Casell [8]. Futility was defined as 
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a therapeutic measure considered useless because the objective of providing benefit to the patient 
was very likely to fail. Other data of interest collected were hospital stay, stay in the ICU, time from 
admission to the ICU until the decision was made and time from making the decision until death or 
discharge from hospital.  
Statistical analysis 
Data were presented as absolute numbers and percentages for categoric variables and 
mean±SD for continuous ones. The χ2 test was used for comparing non-continuous variables while the 
means of continuous variables were compared using the Student t test for unpaired data. A logistic 
regression model was used to analyze the factors predictive of mortality. Confounding factors of poor 
prognosis were considered to be age, sex, APACHE II, organ failure at the time of inclusion and 
comorbidity. Survival and the influence of type of LC were studied using the Kaplan-Meier method. 
Results 
Between 1 February 2004 and 28 February 2006 we admitted a total of 1458 patients to the 
ICU. Their mean age was 65.3±15.9 years and 64.6% were women. The mean APACHE II score was 
15.4±8.1 and the mean stay was 5.6±9.6 days. In total, 287 patients died (19.7%). The most common 
diseases on admission were ischemic heart disease (28.1%), severe sepsis (27.4%) and chronic 
obstructive pulmonary disease (7%). The mortality rate for each of these diseases was 5.9%, 34.8% 
and 8.9%, respectively. Of the total number of deaths in the ICU, severe sepsis accounted for 48.4%. 
Life-prolonging measures were withdrawn or withheld in 97 patients (6.7%). Eighty-five patients 
died (30.3% of the total deaths and 89.6% of patients with LC). Consent for LC was obtained from the 
family in 99%. 
The characteristics of the patients for whom LC was implemented are presented in Table 1. 
Within the withdrawal approach, the most common action was withdrawal of vasoactive drugs 
(29.2%), followed by mechanical ventilation (18.6%) and oxygen therapy (11%). With regard to 
withholding of life support, mechanical ventilation was not applied in 15.5% of the patients, followed by 
continuous replacement techniques in 8.2% and vasoactive drugs in 3%.  
With regard to the rationale for decision making, futility was the most common reason, given in 
85% of the cases, followed by quality of life in 31.9% and suffering in 6.2%. Disease progression was 
accompanied by palliative measures with sedatives and analgesics in 95% and 60% of the patients, 
respectively. On adjustment for age, sex, APACHE II, SOFA at the time of inclusion, number of failing 
organs, and type of LC, only withdrawal influenced mortality, with an OR of 2.3 (95% CI, 1.4-4.2; 
p<0.001). Mortality among patients in whom LC was applied was 89.6%. We studied whether there 
were any factors predictive of survival in patients in whom LC was applied, and did not find any 
significant differences in comorbidity of the patients or in the number of failing organs at the time of 
inclusion, although significant differences in the severity criteria were apparent (Table 2). However, on 
constructing a logistic regression model with adjustment for age, sex, severity criteria (APACHE II, 
SOFA on admission and number of affected organs), immunosuppression (AIDS, cancer and 
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corticosteroid administration for a week or more) and the different life support techniques, we did not 
see any influence on mortality compared to patients who were discharged from hospital.  
Follow-up was available for patients who were discharged after LC (12 patients). Six patients 
died during the first 6 months and 6 were still alive 1 year later. Of those who died, 50% had a good 
quality of life when they were admitted to the ICU.  
Discussion 
LC begins the moment that continuing with life support measures is considered futile or of no 
benefit. General acceptance of this on the part of the medical team and the patient’s family is essential 
for an appropriate and acceptable outcome of the process. 
In this study, we found that, although LC is a routine practice in ICUs, in our unit, it was applied 
in only 6.7% of the patients admitted to our unit. This is lower than the percentage reported in other 
studies, where it varied between 11% in France [9], 9.9% in Great Britain [10], 10%-9.8% in a study of 
European Union countries [11] and 9.6% in the Lebanon [12] and Greek 41% [21], . It is however 
similar to that reported by Esteban et al [4] in their study of application of LC in 7 Spanish ICUs. The 
lower percentage in our study could be because we did not include patients with a do not resuscitate 
order.  
One of our main findings was that the deaths of patients in whom it was decided to withhold or 
withdraw life support measures accounted for 30.3% of all mortality—similar to the percentage 
reported by Wunsch et al [10] but significantly lower than the 45% to 70% reported by other authors 
[12]. Our results differ from other studies in that a greater proportion of the deaths occurring in the ICU 
were due to LC [13]. Bearing in mind that the overall mortality of our patients did not differ from the 
established average (around 19.7% of patients admitted) and that the mean APACHE II in patients for 
whom life support is maintained was 15 (figures similar to other studies [9,11]), it is not clear why most 
of the deaths are not due to application of LC. It may partly be due to the fact that patients with do not 
resuscitate order were not included. On the other hand, mortality within the group of patients for whom 
LC was decided was 89.6% (95.3% in those with withdrawal and 72.7% in those with withholding of 
life support). These figures are slightly higher than the study of Ferrand et al [9], who reported 
mortality of 78% (92% for withdrawal and 57% for withholding). 
The lack of an established consensus or widely accepted guidelines means that decision 
making when treating these patients is a difficult process and is often made using subjective criteria 
[20]), For these reasons, often with the desire on the part of the families to apply whatever means are 
necessary, the decision to withhold or withdraw life support in our unit might be taken at a later stage 
compared to other ICUs in other European countries. Thus, in our study, the mean stay in the ICU was 
10.5 days and the delay until adopting LC 8.6 days. Both these are much longer than in other studies 
[1,11], where the times are 4 and 2 days, respectively. The fact that a high percentage of patients in 
whom LC was applied were diagnosed with severe sepsis might have had an influence. In such cases, 
the decisions are generally made later given that this is a potentially curable disease and the 
resources available were applied until considered futile. It is of relevance that there was a high level of 
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acceptance on the part of the families when deciding jointly to initiate LC. This is in contrast to 
Esteban et al [4], who reported that the family was not consulted about the decision for LC in 28.3% of 
the cases. The high degree of consensus achieved in our study may be because LC was initiated later 
thereby allowing the family members more time to accept and adapt to the life-threatening situation of 
the patient. Another factor might be that in our unit, it is always the treating physician who informs the 
family of the situation, and a bond of trust is generally established between them. Probably as a result 
of this consensus and the high degree of acceptance, we recorded the moment in which—jointly in a 
unit meeting and in consultation with the family—it was decided to apply LC in 99.8% of the medical 
records. This contrasts with the study reported by Vincent et al [13] of ICUs in different European 
countries (in particular Spain, Italy and Greece), in which the decision for LC is not usually recorded. 
With regard to deciding on LC, of note is that withdrawal was adopted in 65.9% of the patients 
versus 34% in whom life-support measures were withheld. This is in agreement with data obtained in 
studies carried out in southern Europe compared to other European regions and the United States 
where no differences were found between adopting one or other type of measure [1,9,11]. This 
discrepancy may be due to different religious beliefs, customs, and moral convictions in each country. 
Withdrawal of life support is generally associated with higher mortality and earlier death. In our 
study, the estimated mean time from making the decision until death was 41 hours in the case of 
withdrawal and 96 hours in the case of withholding. We did not find any significant differences in the 
number of failing organs, APACHE II or SOFA that might explain this difference, as suggested in the 
study of Sprung et al [11] and Vincent et al [13]. According to these authors, the patients in whom LC 
in the form of withdrawal of life support is applied are usually the most critical or unstable. 
Overall, the time between starting LC and death or discharge was 68 hours, which is much 
longer than the time reported by Sprung et al [11] and Wunsh et al [10], Jensen et al [21], (15, 2 hours, 
36 hours, respectively). A number of explanations could be offered for these observations. In some 
cases, we delayed the process to help the family adapt to the loss of a loved one. At other times, the 
delay was to allow the implicated family members time to arrive at the bedside or to avoid death during 
the early hours of the morning. On the other hand, it may be that the process of withdrawal of life-
support measures was slow and progressive or that the LC involved withholding or withdrawing less 
aggressive measures.  
Among the reasons given for deciding on LC, the most frequent was futility (85%) followed by 
poor quality of life (31.9%) and suffering (6.1%). This is in line with the findings of other studies [1, 16, 
18, 21,22]. It seems clear that the balance between applying aggressive measures and poor patient 
prognosis is a concept that is widely accepted in our group. Reciently Cabré et al proposed a model 
showed that in poblation with multiorganic failure those older than 60 years and with SOFA score 
higher than 9 for at least 5 days were unlikely to survive [19]. 
Like Wood et al [14] and Smedira et al [2] we found that suffering was not a principal factor 
when making end-of-life decisions. Costs were not included as a limiting factor because we did not 
consider them decisive, as reflected in other studies conducted, like ours, in public centers financed by 
the national social security system [13,16]. However, it is true that when withholding life-support 
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measures, the most aggressive and costly were considered (mechanical ventilation followed by renal 
replacement techniques). 
There is regional and international variability in the approaches to end-of-life care. Randall and 
Vincent report the end-of-life care requires adequate training, good communication between the 
clinician and family, and the collaboration of a well functioning interdisciplinary team [20.] More studies 
are necessary to investigate the attitude of the medical teams, the perceptions of the patients and their 
family members, prognosis, future quality of life, etc, as well as clearer ethical and legal criteria to 
establish guidelines to support and standardize application of LC with the ultimate aim of providing 
patients with a fundamental right—a dignified death.  
Our study is subject to several limitations that might interfere with the interpretation of the 
results. This was a prospective, observational study in which the attitudes of the physicians may have 
been influenced by knowing that they were under observation. Thus the patient records may have 
been filled out with greater care or the families consulted more often, giving the appearance of a 
longer decision process than in other studies. However, the general impression of in our unit is that 
our attitude before and after the study did not change significantly. In addition, we have not recorded 
important data such as the participation of nursing staff, religious orientation, degree of relationship of 
the family members who agree on decision making with us, etc. Likewise, we have not recorded the 
patients for whom a do not resuscitate order was applied. This could mean that both the number of 
patients to whom LC was applied and the associated mortality are lower than other studies. 
Conclusions 
In conclusion, the most commonly applied type of LC was withdrawal of life support. We did not 
find any factors on admission predictive of the choice of type of LC. Withdrawal of life support was 
more strongly related to mortality than withholding. 
Further studies are required in this field to help the clinician in making decisions that are still 
difficult due to the lack of clear standars on the futility of certain treatments 
List of abbreviations 
APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; LC, 
limitation of care; SOFA, Sequential Organ Failure Assessment. 
Keys messages 
Intensive Care Service should establish protocols of withholding and withdrawing in your clinical 
practice 
There aren´t factors on admission predictive of the choice of type of LC.  
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Table 1. Characteristics of the population according to type of limitation of care 
 WDLS WHLS P 
Number 64 33  
Age 71.3 ± 11.8 71.8 ±16.9 NS 
Sex, female 21 (32.8%) 13 (39.4%) NS 
APACHE II 21.6 ± 7.3 20.6 ± 6.9 NS 
SOFA on implementing LC 8.4 ± 3.8 7.7 ± 4.3 NS 
Stay in ICU (hours) 313.5 ±401.9 240.4 ± 172.9 NS 
Stay until decision made (hours) 273.2 ± 400.5 144.2 ± 166.2 0.02 
Stay from decision until death or discharge 
from hospital (hours) 
40.5 ± 7.3 96.3 ± 70.3 0.01 
Hospital stay (hours) 399.8 ± 433.5 377.1 ± 321.6 NS 
No. organs affected initially 2.6 ± 1.5 2.6 ± 1.6 NS 
Diagnosis on implementing LC (%)    
Septic shock  16 (25%) 15 (45.4%) NS 
Cardiogenic shock 8 (12.5%) 10 (30.3%) NS 
COPD 5 (7.8%) 5 (15.1%) NS 
Stroke/cerebral anoxia 24 (37.5%) 1 (3%) NS 
Respiratory distress 7 (10.9%) 0 NS 
Cancer 4 (6.2%) 2 (6%) NS 
Initial multiorgan failure    
Cardiovascular 35 (54.6%) 19 (57.5%) NS 
Respiratory 38 (59.3%) 16 (48.4%) NS 
Renal 26 (40.6%) 16 (48.4%) NS 
Hepatic 20 (31.2%) 10 (30.3%) NS 
Hematologic 10 (15.6%) 5 (15.1%) NS 
Digestive 19 (29.6%) 8 (24.2%) NS 
Number of organs    
≤ 2 organs 37 (57.8%) 15 (45.5%) 0.05 
3 organs 10 (15.6%) 8 (24.2%) NS 
4 organs 8 (12.5%) 6 (18.1%) NS 
≥ 5 organs 9 (14%) 4 (12.1%) 0.05 
Techniques during LC    
Mechanical ventilation 38 (59.3%) 12 (36.3%) 0.02 
Inotropics 5 (7.8%) 6 (18.1%) NS 
Dialysis 3 (4.6%) 0 NS 
Antibiotics 25 (39%) 12 (36.3%) NS 
Artificial nutrition 18 (28.1%) 17 (51.5%) NS 
Tracheotomy 7 (10.9%) 1 (3%) NS 
Dead 61 (95.3%) 24 (72.7%) 0.003 
Alive 3 (4.7%) 9 (27.3%)  
Abbreviations: WDLS, withdrawal of life support; WHLS, withholding of life support. 
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Table 2. Severity criteria of the patients with LC 
 Dead Alive  P 
Number of patients 85 12  
Age (years) 71 ± 13.9  74.9 ± 13.19 NS 
APACHE II 21.7 ± 7.3 17.4 ± 5.2 0.03 
SOFA on implementing LC 8.5 ± 3.4 5.8 ±3.8 0.03 
Number of organs on implementing LC 2.7 ± 1.5 1.6 ± 1.6 0.04 
Initial SOFA ≥11 31 1 0.05 
 
